Research output per year
Research output per year
Personal profile
Short presentation
Primary research areas
Inflammatory joint diseases, treatment strategies, predictors, RCT, observational studies, biomarkers, imaging
Short presentation
Education
Medical doctor 1988 (University of Copenhagen)
Specialized in rheumatology (2000)
Academic degrees
PhD 1997 (University of Copenhagen)
DMSc 2011 (University of Copenhagen)
Current position
Professor at University of Copenhagen
Consultant in Rheumatology at Glostrup Hospital
Chair of the steering committee for the DANBIO registry
Keywords
- Faculty of Health and Medical Sciences
- rheumatoid arthritis
- psoriatic arthritis
- ankylosing spondylitis
- spondyloarthritis
- RCT
- observational studies
- epidemiology
- DANBIO
- biomarkers
- treatment strategy
Fingerprint
Dive into the research topics where Merete Lund Hetland is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Patients' views on routine collection of patient-reported outcomes in rheumatology outpatient care - a multicenter focus group study
Primdahl, J., Jensen, D. V., Meincke, R. H., Jensen, K. V., Ziegler, C., Nielsen, S. W., Dalsgaard, L., Kildemand, M., Hetland, M. L. & Esbensen, B. A., 1 Sept 2020, In: Arthritis Care & Research.Research output: Contribution to journal › Journal article › Research › peer-review
-
Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: Possible fallout on non-medical switching' by Cantini and Benucci
Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard Pedersen, D., Sørensen, I. J., Andersen, L. S., & 4 others, 2020, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Comment/debate › Research
-
Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias
Ornbjerg, L. M., Christensen, K. B., Tennant, A. & Hetland, M. L., 2 Jan 2020, In: Scandinavian Journal of Rheumatology.Research output: Contribution to journal › Journal article › Research › peer-review
-
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis
Curtis, J. R., Flake, D. D., Weinblatt, M. E., Shadick, N. A., Østergaard, M., Hetland, M. L., Brahe, C. H., Hwang, Y. G., Furst, D. E., Strand, V., Etzel, C. J., Pappas, D. A., Wang, X., Hwang, C. C., Sasso, E. H., Gutin, A., Hitraya, E. & Lanchbury, J. S., 1 May 2019, In: Rheumatology. 58, 5, p. 874-883Research output: Contribution to journal › Journal article › Research › peer-review
-
Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients
Secher, A. E., Glintborg, B., Gudbergsen, H., Krogh, N. S., Sørensen, I. J., Jensen, D. V., Christensen, R., Skougaard, M., Pedersen, P. L. & Hetland, M. L., 4 May 2019, In: Scandinavian Journal of Rheumatology. 48, 3, p. 178-184Research output: Contribution to journal › Letter › peer-review
-
Correction: Polymorphisms at phase I-metabolizing enzyme andhormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritispatients
Canet, L. M., Sánchez-maldonado, J. M., Cáliz, R., Rodríguez-ramos, A., Lupiañez, C. B., Canhão, H., Martínez-bueno, M., Escudero, A., Segura-catena, J., Sorensen, S. B., Hetland, M. L., Soto-pino, M. J., Ferrer, M. A., García, A., Glintborg, B., Filipescu, I., Pérez-pampin, E., González-utrilla, A., Nevot, M. Á. L., Conesa-zamora, P., & 10 others, 1 Dec 2019, In: The Pharmacogenomics Journal. 19, 6, p. 582 1 p.Research output: Contribution to journal › Journal article › Research
-
Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs?
Glintborg, B., Ibsen, R., Bilbo, R. E. Q., Lund Hetland, M. & Kjellberg, J., 2019, In: RMD Open. 5, 2, 9 p., e001016.Research output: Contribution to journal › Journal article › Research › peer-review
-
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care: 2-year outcomes and predictors
Brahe, C. H., Krabbe, S., Østergaard, M., Ørnbjerg, L., Glinatsi, D., Røgind, H., Jensen, H. S., Hansen, A., Nørregaard, J., Jacobsen, S., Terslev, L., Huynh, T. K., Jensen, D. V., Manilo, N., Asmussen, K., Frandsen, P. B., Boesen, M., Rastiemadabadi, Z., Carlsen, L. M., Møller, J. M., & 2 others, 1 Jan 2019, In: Rheumatology. 58, 1, p. 110-119Research output: Contribution to journal › Journal article › Research › peer-review